Results 101 to 110 of about 7,511 (159)

Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement. [PDF]

, 2015
Bartalena L, MACCHIA, PAOLO EMIDIO, Marcocci C, Salvi M, Vermiglio F.   +4 more
core   +1 more source

Psychiatric complications in Graves’ disease

European Thyroid Journal
Background: Mood disorders are common in Graves’ disease despite treatment. The pathogenic mechanisms involved are unknown and so is whether previous psychiatric disease influences these symptoms.
Mats Holmberg, Helge Malmgren, Peter F Berglund, Birgitta Johansson, Helena Filipsson Nyström   +4 more
doaj   +1 more source

Biomarkers of ocular surface disease using impression cytology [PDF]

, 2017
Aronni S, Baudouin C, Brignole F, Danjo Y, Eberwein P, Hagan S, Kurpińska M, Mocanu CL, Roy P, Shiraki Y, Suzanne Hagan   +10 more
core   +2 more sources

Hyperthyroid heart disease: Diagnostic and therapeutic aspects [PDF]

, 1990
Reinwein, Dankwart, Scriba, P. C., Scriba, Peter Christian   +2 more
core   +1 more source

ePoster

European Journal of Neurology, Volume 32, Issue S1, June 2025.
wiley   +1 more source

Graves’ Orbitopathy

International Journal of Endocrinology, 2015
Yuji Hiromatsu, Jack R. Wall, George J. Kahaly, Hirohiko Kakizaki   +3 more
doaj   +1 more source

Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface [PDF]

, 2016

core   +1 more source

Sirolimus for the treatment of Graves' orbitopathy. [PDF]

Thyroid Res
Comi S, Sabini E, Cosentino G, Santini F, Marinò M.   +4 more
europepmc   +1 more source

Assessment of disease activity in Graves' orbitopathy. [PDF]

Front Ophthalmol (Lausanne)
Potvin ARGG, Lacraru IC, Bisschop PH, de Win MML, Eckstein AK, Saeed P.   +5 more
europepmc   +1 more source

Unravelling the pathogenic mechanisms in Graves' orbitopathy. [PDF]

Eur Thyroid J
Lee ACH, Kahaly GJ.
europepmc   +1 more source